Catching up with Roberto Bellini one year after he sold BELLUS Health to GSK for $2 billion
Roberto Bellini introduces us to his new investment firm and looks back on lessons learned from selling BELLUS to GSK.
top of page
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Allucent Clinical Research Organization is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.
bottom of page